Migdal Insurance & Financial Holdings’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $658M | Buy |
|
|||||
|
2025
Q2 | $481M | Buy |
|
|||||
|
2025
Q1 | $405M | Buy |
|
|||||
|
2024
Q4 | $574M | Buy |
|
|||||
|
2024
Q3 | $459M | Sell |
|
|||||
|
2024
Q2 | $473M | Sell |
|
|||||
|
2024
Q1 | $421M | Buy |
|
|||||
|
2023
Q4 | $302M | Buy |
|
|||||
|
2023
Q3 | $276M | Buy |
|
|||||
|
2023
Q2 | $178M | Buy |
|
|||||
|
2023
Q1 | $207M | Buy |
|
|||||
|
2022
Q4 | $197M | Buy |
|
|||||
|
2022
Q3 | $173M | Buy |
|
|||||
|
2022
Q2 | $147M | Sell |
|
|||||
|
2022
Q1 | $196M | Buy |
|
|||||
|
2021
Q4 | $167M | Sell |
|
|||||
|
2021
Q3 | $207M | Buy |
|
|||||
|
2021
Q2 | $196M | Buy |
|
|||||
|
2021
Q1 | $229M | Sell |
|
|||||
|
2020
Q4 | $191M | Buy |
|
|||||
|
2020
Q3 | $158M | Sell |
|
|||||
|
2020
Q2 | $270M | Sell |
|
|||||
|
2020
Q1 | $197M | Buy |
|
|||||
|
2019
Q4 | $125M | Buy |
|
|||||
|
2019
Q3 | $30.8M | Buy |
|
|||||
|
2019
Q2 | $32.1M | Buy |
|
|||||
|
2019
Q1 | $53.7M | Buy |
|
|||||
|
2018
Q4 | $46.5M | Buy |
|
|||||
|
2018
Q3 | $43.5M | Sell |
|
|||||
|
2018
Q2 | $54.1M | Sell |
|
|||||
|
2018
Q1 | $48.4M | Sell |
|
|||||
|
2017
Q4 | $54.7M | Sell |
|
|||||
|
2017
Q3 | $106M | Buy |
|
|||||
|
2017
Q2 | $192M | Buy |
|
|||||
|
2017
Q1 | $114M | Sell |
|
|||||
|
2016
Q4 | $165M | Buy |
|
|||||
|
2016
Q3 | $173M | Sell |
|
|||||
|
2016
Q2 | $375M | Buy |
|
|||||
|
2016
Q1 | $207M | Sell |
|
|||||
|
2015
Q4 | $268M | Buy |
|